Myointimal Hyperplasia: Pathogenesis and Implications. 1. In Vitro Characteristics

Artificial Organs

Volumn 15, Issue 1, 1991, Pages 42-55

  Painter, Thomas A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTERY GRAFT; HUMAN; HUMAN TISSUE; HYPERPLASIA; NONHUMAN; REVIEW; SMOOTH MUSCLE FIBER;

ANIMAL; ENDOTHELIUM, VASCULAR; GRAFT OCCLUSION, VASCULAR; HUMAN; HYPERPLASIA; LIPIDS; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR;

ANIMALIA;

EID: 0025966556     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1991.tb00758.x     Document Type: Article

References (164)

1. Intimal and neointimal fibrous proliferation causing failure of arterial reconstructions
2. Biologic fate of autogenous vein implants as arterial substitutes: clinical, angiographic and histopathologic observations in femoro–politeal operations for atherosclerosis
3. Intimal hyperplasia as a complication of the use of the polytet–rafluoroethylene graft for femoral–popliteal bypass
4. Management of early and late thrombosis of expanded polytetrafluoroethylene (PTFE) femoropopliteal bypass grafts: favorable prognosis with appropriate reoperation
5. Expanded polytetrafluoroethylene vascular grafts
6. Progressive and late obstruction of an aortocoronary venous bypass graft
7. Pathologic changes in aortocoronary saphenous vein grafts
8. Pathologic changes in aortic–coronary arterial saphenous vein grafts
9. Intimal hyperplasia, a cause of radial artery aortocoronary bypass graft failure
10. Recurrent carotid stenosis: a five–year series of 65 reoperations
11. Improved myocardial function during exercise after successful percutaneous transluminal angioplasty
12. Coronary restenosis rates in consecutive patient series one year post–successful angioplasty (Abstract)
13. Results of coronary angioplasty and implications for the future
14. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty
15. Diffuse arterial narrowing as a result of intimal proliferation: a delayed complication of embolectomy with Fogarty balloon catheter
16. Early myointimal hyperplasia after balloon catheter embolectomy: effect of shear forces and multiple withdrawals
17. Intimal hyperplasia and neointima: an ultrastructural analysis of thrombosed grafts in humans
18. Electron microscopic studies of experimentally produced fibromuscular arterial lesions
19. Downstream anastomotic hyperplasia: a mechanism of failure in Dacron arterial grafts
20. Thickening of arterial intima in rat cardiac allografts: a light and electron microscopic study
21. Late failure in vein grafts: mediating factors in subendothelial fibromuscular hyperplasia
22. Intimal hyperplasia in arterial autogenous vein grafts: a new animal model
23. Mechanisms of arterial graft failure 1. Role of cellular proliferation in early healing of PTFE prostheses
24. Vein graft patency and intimal proliferation after aortocoronary bypass: early and long–term angiopathologic correlations
25. Differential staining of acidic glycosaminoglycans (mucopolysaccharides) by alcian blue in salt solution
26. Proteoglycans in primate arteries. III. Characterization of the proteoglycans synthesized by arterial smooth muscle cells in culture
27. Proteoglycans in primate arteries II. Synthesis and secretion of glycosaminoglycans by arterial smooth muscle cells in culture
28. The smooth muscle cell in culture
29. Increased mitotic activity in aortas of swine after 3 days of cholesterol feeding
30. Comparison of vascular smooth muscle cells from adult human, monkey, and rabbit in primary culture and in subculture
31. Association of DNA synthesis and apparent differentiation of aortic smooth muscle cells in vitro
32. Phenotypic–dependent response of cultured aortic smooth muscle to serum mitogens
33. Aortic media explants. Cell proliferation and production of mucopolysaccharides, collagen and elastic tissue
34. The smooth muscle cell. I. In vivo synthesis of connective tissue proteins
35. The smooth muscle cell. 11. Growth of smooth muscle cell in culture and formation of elastic fibers
36. Collagen synthesis by monkey arterial smooth muscle cells during proliferation and quiescence in culture
37. Biosynthesis of Type I and III collagens by cultured smooth muscle cells from human aorta
38. Synthesis of Types I and II procollagen and collagen by aortic smooth muscle cells in vitro
39. Synthesis of Type I collagen by human smooth muscle cells in vitro
40. Subcellular fractionation and morphology of calf aortic smooth muscle cells. Studies on whole aorta, aortic explants, and subcultures grown under different conditions
41. Cell density and estradiol modulation of procollagen type III in cultured calf smooth muscle cells
42. The smooth muscle cell HI eastin synthesis in arterial smooth muscle cell culture
43. Synthesis of glycosaminoglycans by cultured rabbit smooth muscle cells
44. A serum–free medium for the growth of muscle cells in culture
45. Morphogenesis of vascular smooth muscle in atherosclerosis in cell culture
46. A platelet dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro
47. Platelet factor–the principle stimulant in serum for DNA synthesis of cells in culture
48. Platelets as a source of fibroblast growth–promoting activity
49. Hormonal requirements for growth of arterial smooth muscle cells in vitro: an endocrine approach to atherosclerosis
50. Culture of quiescent arterial smooth muscle cells in a defined serum–free medium
51. Human platelet–derived growth factor (PDGF): purification of PDGF–1 and PDGF–II and separation of their reduced sub–units
52. Human platelet derived growth factor (PDGF): amino–terminal amino–acid sequence
53. The c–sis gene encodes a precursor of the P chain of platelet derived growth factor
54. Purification and properties of porcine platelet derived growth factor
55. Simian sarcoma virus onc Gene, v–sis, is derived from the gene (or genes) encoding a platelet derived growth factor
56. Plate–derived growth factor is structurally related to the putative transforming protein p28SIS of simian sarcoma virus
57. Platelet a–granules contain a growth factor for fibroblasts
58. Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells
59. A macrophage–dependent factor that stimulates the proliferation of fibroblasts in vitro
60. An endothelial cell derived growth factor
61. Cultured endothelial cells produce a platelet–derived growth factor–like protein
62. Developmentally regulated production of platelet derived growth factorlike molecules
63. Arterial smooth muscle cells in primary culture produce a platelet derived growth factor–like protein
64. Platelet derived growth factor
65. Human platelet derived growth factor: Structure and function
66. Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate
67. Migration of cultured vascular cells in response to plasma and platelet derived factors
68. Attachment of smooth muscle cells to collagen and their migration toward platelet derived growth factor
69. Platelet derived growth factor is a chemoattractant for vascular smooth muscle cells
70. Chemotaxis of monocytes and neutrophils to platelet derived growth factor
71. Platelet–derived growth factor binds specifically to receptors on vascular smooth muscle cells and the binding becomes nondissocia–ble
72. An ordered sequence of events is required before BALB/C–3T3 cells become committed to DNA synthesis
73. Platelet derived growth factor II. Specific binding to cultured cells
74. Interaction of circulating cell–derived and plasma growth factors in stimulating cultured smooth muscle cell replication
75. Observations on human smooth muscle cell cultures from hyperplastic lesions of prosthetic bypass grafts: production of a platelet derived growth factor–like mitogen and expression of a gene for a platelet–derived growth factor receptor–a preliminary study
76. Exposure to platelet–derived growth factor modulates the porcine aortic smooth muscle cell response to somatomedin–C
77. Variables controlling the secretion of a so–matomedin–like peptide by cultured porcine smooth muscle cells
78. Blumenfeld 00. Ascorbate–generated endogenous extracellular matrix affects cell protein synthesis in calf aortic smooth muscle cells
79. Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication–stimulating activity (an insulin–like growth factor) using antibodies to the insulin receptor
80. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells
81. Stimulatory effect of insulin on aortic smooth muscle cell migration induced by 12–hydroxy–5,8,10,14–eicosatertraenoic acid and its modulation by elevated extracellular glucose levels
82. Tobacco constitutes are mitogenic for arterial smooth muscle cells
83. Induction of cholecystitis and pneumonitis by inhalation of cigarette smoke constituents
84. The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle events: studies with vascular smooth muscle cells and endothelial cells
85. Ceil cycle–dependent inhibition of human vascular smooth muscle cell proliferation by prostaglandin E
86. Platelet–activating factor stimulates prostaglandin synthesis in cultured cells
87. Stimulation of aortic smooth muscle cell mitogenesis by serotonin
88. Lipoproteins increase growth of mitogen–stimulated arterial smooth muscle cells
89. Atherosclerosis and the arterial smooth muscle cell
90. Stimulation of proliferation in stationary primary cultures of monkey and rab bit aortic smooth muscle cells
91. Effect of lipoprotein on in vitro synthesis of DNA in aortic tissue
92. Lipid accumulation in arterial smooth muscle: influence of phenotype
93. Serum lipoprotein composition, platelet factor and arterial smooth muscle cells
94. Inhibition of vascular smooth muscle cell growth by endothelial–cell derived heparin: possible role of a platelet endoglycosidase
95. Inhibition of rat arterial smooth muscle ceil proliferation by heparin. II. In vitro studies
96. The separation of active and inactive forms of heparin
97. Binding and internalization of heparin by vascular smooth muscle ceils
98. Effect of heparin on vascular smooth muscle cells. I. Cell metabolism
99. Effect of heparin on vascular smooth muscle cells. II. Specific protein synthesis
100. Cyclic stretching stimulates synthesis, of matrix components by arterial smooth muscle cells in vitro
101. Orientation of cultured arterial smooth muscle cells growing on cyclically stretched substrates
102. The effect of centrifugal force on glycosaminoglycan production by aortic smooth muscle cells in culture
103. Culture and identification of large vessel endothelial cells
104. Human vascular endothelial cells in culture: growth and DNA synthesis
105. New cytoplasmic components in arterial endothelialization
106. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria
107. Fine structure of vascular endothelium in culture
108. Ultrastructural identification of umbilical cord vein endothelium in situ and in culture
109. Factor VIII in the vascular intima: possible importance in hemostasis and thrombosis
110. Antihemophilic factor antigen. Localization in endothelial cells by immunofluorescence microscopy
111. Failure to detect Willebrand factor in cultured porcine endothelial cells
112. Factor VIII related antigen (F VIII RAG) in porcine endothelial cells
113. Growth control in aortic endothelium at wound edges. Cold Spring Harbor 3rd Conference on Cell Proliferation
114. Human vascular endothelial cells in culture. Lack of response to serum growth factors
115. Selection and characterization of bovine aortic endothelial cells
116. Studies of morphologically atypical (“sprouting”) cultures of bovine aortic endothelial cells. Growth characteristics and connective tissue protein synthesis
117. Evidence of reversible morphologic phe–notypes (sprouts) of cultured endothelial cells
118. Signals causing change in morphological phenotype, growth mode and gene expression of vascular endothelial cells
119. Maintenance of integrity in aortic endothelium
120. Vascular wall growth control: the role of the endothelium
121. Intercellular junctions and transfer of small molecules in primary vascular endothelial cultures
122. Endothelial cell motility
123. Support of cell growth by cell lysates
124. Cellular migration and replication in endothelial regeneration. A study using irradiated cultures
125. Migration of adult human vascular endothelial cells: effect of extracellular matrix proteins
126. Capillary endothelial cell cultures: phenotypic modulation by matrix components
127. Mediation of pinocytosis in cultured arterial smooth muscle and endothelial cells by platelet–derived growth factor
128. Cultured endothelial cells do not respond to a platelet–derived growth factor–like protein in an autocrine manner
129. Blockade of autocrine stimulation in simian sarcoma virus–transformed cells reverses down regulation of platelet–derived growth factor receptors
130. Control of proliferation of human endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor epidermal growth factor and thrombin
131. Purified tumor angiogenesis factor enhances proliferation of capillary, but not aortic, endothelial cells in vitro
132. Multiple forms of endothelial cell growth factor: rapid isolation and biological and chemical characterization
133. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor
134. Human endothelial cell growth factor: encoding, nucleotide sequence, and chromosome localization
135. Retina and eye derived endothelial cell growth factors: partial molecular characterization and identity with acidic and basic fibroblast growth factors
136. The characterization of the receptor for endothelial cell growth factor by covalent ligand attachment
137. Interaction of endothelial cell growth factor with heparin: characterization by receptors and antibody recognition
138. Heparin affinity: purification of a tumor–derived capillary endothelial cell growth factor
139. Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain
140. Purification of two distinct growth factors from bovine neural tissue by heparin affinity chromatography
141. Purification and characterization of heparin–binding endothelial cell growth factors
142. Human endothelial cells are chemotactic to endothelial cell growth factor and heparin
143. Growth promoting actions of extracts from mouse submaxillary glands on human endothelial cells in culture
144. Dialyzable factor in human serum of platelet origin stimulates endothelial cell replication and growth
145. Characterization and partial purification of an endothelial cell growth factor from human platelets
146. Cultured endothelial cells produce multiple growth factors for connective tissue oclls
147. Endothelial cell production of growth factors–a possible role in vascular graft failure
148. Biochemical properties of the endothelium–derived growth factor: comparison to other growth factors
149. Cultured endothelial cells produce a platelet–derived growth factor–like protein
150. Expression of the sis gene by endothelial cells in culture and in vivo
151. Cultured human endothelial cells express platelet–derived growth factor B chain: cDNA cloning and structural analysis
152. Regulation of production of a platelet–derived growth factor–like protein by cultured bovine aortic endothelial cells
153. Modulation of the sis gene transcript during endothelial cell differentiation in vitro
154. Alpha–thrombin induces release of platelet–derived growth factor–like molecule(s) by cultured human endothelial cells
155. Thrombin stimulates c–sis gene expression in microvascular endothelial cells
156. Human endothelial cells in culture produce platelet–activating factor (l–alkyl–2–acetyl–SN–glycero–3–phosphocholine) when stimulated with thrombin
157. The effect of lipoproteins on the synthesis of prostacyclin, Von Willebrand factor and apolipoproteins AI and A–II in cultured human endothelial cells
158. Modified low density lipoproteins suppress production of a platelet–derived growth factor–like protein by cultured endothelial cells
159. Fish oils inhibit endothelial cell production of platelet–derived growth factor–like protein
160. Monocyte chemotactic factor produced by large vessel endothelial cells in vitro
161. Characterization of the adhesion of the human monocytic cell line U937 to cultured endothelial cells
162. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic
163. Participation of the endothelium in the development of the atherosclerotic plaque